Central nervous system
Central nervous system

Subacute combined degeneration

Definition:
A disorder caused by Vitamin B12 deficiency and characterized by weakness and abnormal sensations, mental problems, and vision difficulties.

Alternative Names:
Subacute combined degeneration of the spinal cord; SCD

Causes, incidence, and risk factors:

Subacute combined degeneration of the spinal cord is a result of Vitamin B12 deficiency. Lack of this vitamin is often caused by pernicious anemia, an autoimmune blood disorder that prevents absorption of Vitamin B12. Although symptoms of anemia are the most common manifestation of this disorder, subacute combined degeneration can also occur without such symptoms.

While Vitamin B12 deficiency can rarely be caused by diet (Vegans, who eat no dairy or meat products, are most susceptible), the most common cause is an inability to absorb the vitamin from the intestines.

Subacute combined degeneration primarily affects the spinal cord, but it can also include damage to the brain, the nerves of the eye, and the peripheral (body) nerves. The damage is diffuse. Initially, there is damage to the myelin sheath (the covering of the nerve that speeds transmission of nerve impulses), followed by destruction of the axon portion of the cell and eventually, destruction of the entire nerve cell. The mechanism by which lack of B12 damages nerves is not clear. It is thought that lack of this vitamin causes an abnormal formation of fatty acids, which are used by the body to build cell membranes and the nerve myelin sheath.

Risks include lack of dietary B12 (rare), inherited or acquired lack of the factor needed to absorb B12 from the intestines, antibodies to this factor (pernicious anemia) which prevents its absorption, and disorders of the small intestine, such as Crohn's disease as well as other malabsorptive conditions which can occur after gastrointestinal surgery.

Symptoms:
Speech impairment may also be associated with this disease.
Signs and tests:
An examination usually shows symmetrical sensorimotor polyneuropathy, with muscle weakness and sensation disturbance. Reflexes are often abnormal. Muscles may develop spasticity. There is a loss of position sense (awareness of body position) and sense of touch, pain, and temperature may be diminished. Mental changes are variable, from mild forgetfulness to complete dementia or psychosis. Severe dementia is uncommon, but in some cases, it is the initial symptom of the disorder. An eye examination may indicate damage to the optic nerve (optic neuritis), with abnormal pupil responses, inflammation or atrophy of the optic nerve (visible on retinal exam), decreased visual acuity, and other changes.
  • CBC may show anemia. If folic acid has been used to treat anemia, neurologic symptoms may develop even if the anemia is no longer evident and this may cause diagnostic confusion.
  • Serum B12 levels are low.
Treatment:
Early treatment improves the chances of a good outcome, so the disease should be treated promptly.

Vitamin B12 is given, usually by intramuscular injection, in large doses. Injections are often given daily for about 1 week, then weekly for about 1 month, then monthly. Vitamin B12 injections must continue throughout life to prevent recurrence.
Expectations (prognosis):
Response to treatment depends on how long symptoms have been present before treatment. Treatment within a few weeks usually results in complete recovery. If symptoms have been present for longer than 1 or 2 months, partial recovery can be expected. If symptoms have been present for many months, progression of symptoms may be slowed or stopped, but recovery of lost function is unlikely. B12 injections must be continued lifelong or symptoms will recur.

Untreated, the disorder results in progressive and irreversible damage to the nervous system.
Complications:
Complications can include permanent, progressive loss of nerve functions.
Calling your health care provider:
Call your health care provider if abnormal sensations, muscle weakness, or other symptoms of subacute combined degeneration develop, particularly if there is a personal or family history of pernicious anemia or other risk factors. Early diagnosis and treatment improve the chance of a good outcome.
Prevention:
None is known, but treatment of the disorder prevents recurrence.

Review Date: 11/9/2001
Reviewed By: Galit Kleiner-Fisman MD, FRCPC, Department of Neurology, University of Toronto, Toronto, Ontario, Canada. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.